Subtopic Deep Dive

Deuterium Kinetic Isotope Effects
Research Guide

What is Deuterium Kinetic Isotope Effects?

Deuterium Kinetic Isotope Effects (DKIEs) measure the change in reaction rates when hydrogen atoms in a substrate are replaced by deuterium due to differences in zero-point energy and bond strengths.

DKIEs distinguish primary effects (rate-determining C-H/D bond cleavage, kH/kD up to 7) from secondary effects (adjacent bonds, kH/kD ~1.2-2). Enzymatic and CYP450 metabolism studies quantify DKIEs to probe transition states. Over 100 papers since 1967 analyze DKIEs in drug pharmacokinetics and deuteration strategies (Sharma et al., 2011; Foster, 1967).

Curated Papers

Key Challenges

Why It Matters

DKIEs guide deuteration of drugs like deutetrabenazine to slow metabolism and extend half-life, improving therapeutic windows in tardive dyskinesia treatment (Fernandez et al., 2017, 322 citations). In CYP450 reactions, DKIEs predict clearance impacts, enabling rational design of deuterated analogs with reduced dosing frequency (Sharma et al., 2011). Pharmaceutical applications include optimizing aldehyde oxidase-cleared drugs and scaling deuteration for clinical trials (Di Martino et al., 2023; Shao and Hewitt, 2010).

Key Research Challenges

Quantifying Primary vs Secondary DKIEs

Distinguishing primary DKIEs (C-H/D cleavage) from secondary requires site-specific deuteration and precise kinetic assays. Competitive methods using mass spectrometry improve accuracy but demand high isotopic purity (Atkins and Sligar, 1988). Intrinsic KIE extraction from observed values faces masking by downstream steps (Sharma et al., 2011).

Predicting Metabolic Site DKIEs

Computational models struggle to predict CYP450 or oxidase-specific DKIEs without QM/MM validation. Experimental verification needs isotopologues synthesized via photocatalysis or H/D exchange (Liu et al., 2018). System-dependent variations complicate extrapolation across enzymes (Sharma et al., 2011).

Scalable Site-Selective Deuteration

Achieving regioselective deuteration for KIE studies avoids noble metals but faces functional group intolerance. Photocatalytic D2O splitting enables halogenated compound labeling, yet yields drop with complex pharmaceuticals (Liu et al., 2018; Li et al., 2022).

Essential Papers

Deuterium in drug discovery: progress, opportunities and challenges

Rita Maria Concetta Di Martino, Brad D. Maxwell, Tracey Pirali · 2023 · Nature Reviews Drug Discovery · 408 citations

Randomized controlled trial of deutetrabenazine for tardive dyskinesia

Hubert H. Fernandez, Stewart A. Factor, Robert A. Hauser et al. · 2017 · Neurology · 322 citations

This study provides Class I evidence that in patients with TD, deutetrabenazine reduces AIMS scores.

Controllable deuteration of halogenated compounds by photocatalytic D2O splitting

Cuibo Liu, Zhongxin Chen, Chenliang Su et al. · 2018 · Nature Communications · 184 citations

Abstract Deuterium labeling is of great value in organic synthesis and the pharmaceutical industry. However, the state-of-the-art C–H/C–D exchange using noble metal catalysts or strong bases/acids ...

Tritiation of aryl thianthrenium salts with a molecular palladium catalyst

Da Zhao, Roland Petzold, Jiyao Yan et al. · 2021 · Nature · 157 citations

Scalable and selective deuteration of (hetero)arenes

Wu Li, Jabor Rabeah, Florian Bourriquen et al. · 2022 · Nature Chemistry · 147 citations

Abstract Isotope labelling, particularly deuteration, is an important tool for the development of new drugs, specifically for identification and quantification of metabolites. For this purpose, man...

Visible light driven deuteration of formyl C–H and hydridic C(sp<sup>3</sup>)–H bonds in feedstock chemicals and pharmaceutical molecules

Yulong Kuang, Hui Cao, Haidi Tang et al. · 2020 · Chemical Science · 126 citations

A selective hydrogen deuterium exchange reaction with formyl C–H bonds and a wide range of hydridic C(sp<sup>3</sup>)–H bonds has been achieved by merging tetra-<italic>n</italic>-butylammonium dec...

Organophotocatalytic selective deuterodehalogenation of aryl or alkyl chlorides

Yanjun Li, Ziqi Ye, Yu‐Mei Lin et al. · 2021 · Nature Communications · 114 citations

Abstract Development of practical deuteration reactions is highly valuable for organic synthesis, analytic chemistry and pharmaceutic chemistry. Deuterodehalogenation of organic chlorides tends to ...

Reading Guide

Foundational Papers

Start with Atkins and Sligar (1988) for CYP450 mechanistic insights via norcamphor DKIEs, then Sharma et al. (2011) for pharmacokinetic applications across oxidases.

Recent Advances

Di Martino et al. (2023, 408 citations) reviews deuteration opportunities; Fernandez et al. (2017, 322 citations) validates clinical DKIE benefits in deutetrabenazine.

Core Methods

Competitive KIE (LC-MS isotopologue ratios); QM/MM for transition state modeling; Photocatalytic H/D exchange (Liu et al., 2018; Li et al., 2022).

How PapersFlow Helps You Research Deuterium Kinetic Isotope Effects

Discover & Search

Research Agent uses searchPapers('deuterium kinetic isotope effects CYP450') to retrieve Sharma et al. (2011) with 112 citations, then citationGraph reveals 50+ citing works on drug metabolism. exaSearch uncovers synthesis methods from Liu et al. (2018), while findSimilarPapers links to Fernandez et al. (2017) for clinical DKIE applications.

Analyze & Verify

Analysis Agent applies readPaperContent on Sharma et al. (2011) to extract kH/kD ratios for aldehyde oxidase, then verifyResponse with CoVe cross-checks against Atkins and Sligar (1988). runPythonAnalysis fits kinetic models to raw data via NumPy curve_fit, with GRADE scoring evidence strength for primary vs secondary effects.

Synthesize & Write

Synthesis Agent detects gaps in scalable deuteration for CYP substrates, flagging contradictions between Shao and Hewitt (2010) predictions and Fernandez et al. (2017) outcomes. Writing Agent uses latexEditText for KIE mechanism equations, latexSyncCitations for 20-paper review, and latexCompile for publication-ready manuscript with exportMermaid transition state diagrams.

Use Cases

"Analyze kinetic data from Sharma 2011 to compute intrinsic DKIE for aldehyde oxidase substrates"

Analysis Agent → readPaperContent(Sharma2011) → runPythonAnalysis(pandas.read_csv(data), scipy.optimize.curve_fit(kH_kD_model)) → GRADE-verified intrinsic kH/kD=5.2 ±0.4 output.

"Write LaTeX review on DKIEs in deutetrabenazine clinical trials"

Synthesis Agent → gap detection(Fernandez2017 + DiMartino2023) → Writing Agent → latexEditText(section), latexSyncCitations(15 refs), latexCompile → PDF with KIE plots.

"Find code for computational DKIE prediction in P450 reactions"

Research Agent → paperExtractUrls(Atkins1988) → paperFindGithubRepo(QM_MM_KIE) → githubRepoInspect → Python scripts for B3LYP zero-point energy calculations.

Automated Workflows

Deep Research workflow scans 50+ DKIE papers via searchPapers → citationGraph → structured report ranking Sharma et al. (2011) highest for pharmacokinetics. DeepScan applies 7-step CoVe to verify Liu et al. (2018) photocatalysis yields against similar deuteration claims. Theorizer generates hypotheses linking Foster (1967) ketosis DKIEs to modern drug design.

Try Doxa for Deuterium Kinetic Isotope Effects Research

Frequently Asked Questions

What defines a primary deuterium KIE?

Primary DKIEs exceed kH/kD=2 when C-H/D bond breaks in the rate-determining step, due to zero-point energy differences (Atkins and Sligar, 1988).

What methods measure DKIEs in drug metabolism?

Competitive KIE assays with LC-MS track isotopologue ratios; non-competitive methods use full metabolic profiling (Sharma et al., 2011).

Which papers establish DKIEs in CYP450?

Atkins and Sligar (1988) report two-electron reduction evidence in P450cam (75 citations); Sharma et al. (2011) quantify system effects (112 citations).

What are open problems in DKIE applications?

Predicting intrinsic KIEs computationally for complex pharmaceuticals; scaling site-selective deuteration without functional group damage (Di Martino et al., 2023).